I agree that this site is using cookies. You can find further informations here.
X
Budd Haeberlein, Samantha
76  results:
Search for persons X
?
1

Genome-Wide Association Studies of ARIA From the Aducanumab..:

Loomis, Stephanie J. ; Miller, Ryan ; Castrillo-Viguera, Carmen...
Neurology.  102 (2024)  3 - p. , 2024
Link: https://doi.org/10.1212/..
 
?
2

Alzheimer disease neuropathology in a patient previously tr..:

Plowey, Edward D. ; Bussiere, Thierry ; Rajagovindan, Raj...
Acta Neuropathologica.  144 (2022)  1 - p. 143-153 , 2022
Link: https://doi.org/10.1007/..
 
?
3

Analyses à 48 mois de PRIME, une étude de phase 1b chez des..:

Von Rosenstiel, Philipp ; Budd Haeberlein, Samantha ; Patel, Dakshaben...
Revue Neurologique.  175 (2019)  - p. S43 , 2019
Link: https://doi.org/10.1016/..
 
?
4

Toward β-Secretase-1 Inhibitors with Improved Isoform Selec..:

Johansson, Patrik ; Kaspersson, Karin ; Gurrell, Ian K....
Journal of Medicinal Chemistry.  61 (2018)  8 - p. 3491-3502 , 2018
Link: https://doi.org/10.1021/..
 
?
5

P1‐363: MONITORING THE SOLUBLE AMYLOID PRECURSOR PROTEIN AL..:

Höglund, Kina ; Salter, Hugh ; Zetterberg, Henrik...
Alzheimer's & Dementia.  10 (2014)  4S_Part_11 - p. , 2014
Link: https://doi.org/10.1016/..
 
?
6

Glycogen synthase kinase 3: a drug target for CNS therapies:

Bhat, Ratan V. ; Budd Haeberlein, Samantha L. ; Avila, Jesús
Journal of Neurochemistry.  89 (2004)  6 - p. 1313-1317 , 2004
Link: https://doi.org/10.1111/..
 
?
7

UV‐induced apoptosis in SH‐SY5Y cells: Contribution to apop..:

Berglund, C. Mikaela D. ; Radesäter, Ann‐Cathrin ; Persson, Mats A.A..
Journal of Neuroscience Research.  78 (2004)  4 - p. 580-589 , 2004
Link: https://doi.org/10.1002/..
 
?
8

Characterization of long‐term mouse brain aggregating cultu..:

Berglund, C. Mikaela D. ; Aarum, Johan ; Budd Haeberlein, Samantha L....
Journal of Comparative Neurology.  474 (2004)  2 - p. 246-260 , 2004
Link: https://doi.org/10.1002/..
 
?
9

Results from the long‐term extension of PRIME: A randomized..:

Chen, Tianle ; O'Gorman, John ; Castrillo‐Viguera, Carmen...
Alzheimer's & Dementia.  20 (2024)  5 - p. 3406-3415 , 2024
Link: https://doi.org/10.1002/..
 
?
10

Correction to: Characterization of exposure–Clinical Dement..:

Muralidharan, Kumar Kandadi ; Kowalski, Kenneth G. ; Tong, Xiao...
Journal of Pharmacokinetics and Pharmacodynamics.  , 2023
Link: https://doi.org/10.1007/..
 
?
11

Harmonization of tau‐PET in Alzheimer's disease: comparison..:

Leuzy, Antoine ; Dore, Vincent ; Raket, Lars Lau...
Alzheimer's & Dementia.  19 (2023)  S10 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
12

Characterization of exposure–Clinical Dementia Rating–Sum o..:

Muralidharan, Kumar Kandadi ; Kowalski, Kenneth G. ; Tong, Xiao...
Journal of Pharmacokinetics and Pharmacodynamics.  50 (2023)  1 - p. 45-62 , 2023
Link: https://doi.org/10.1007/..
 
?
13

TANGO: a placebo-controlled randomized phase 2 study of eff..:

Shulman, Melanie ; Kong, Jessica ; O'Gorman, John...
Nature Aging.  3 (2023)  12 - p. 1591-1601 , 2023
Link: https://doi.org/10.1038/..
 
?
14

CSF biomarker concordance with amyloid PET in Phase 3 studi..:

Nisenbaum, Laura ; Martone, Robert ; Chen, Tianle...
Alzheimer's & Dementia.  19 (2023)  8 - p. 3379-3388 , 2023
Link: https://doi.org/10.1002/..
 
?
15

Design of a Phase 2, Randomized, Double‐Blind, Placebo‐Cont..:

Ziogas, Nick ; Mummery, Catherine J. ; Rovira, Mercè Boada...
Alzheimer's & Dementia.  19 (2023)  S21 - p. , 2023
Link: https://doi.org/10.1002/..
 
1-15